Table 2.
STUDY | n | Neurological disease | Age (years) | Sex (M/F) | Test |
---|---|---|---|---|---|
Pardo et al.24 | 19 | Chronic stroke | 53.4±12.3 | 9/10 | "Five times sit-to-stand test"* |
Blankevoort et al.22 | 52 | Dementia | 82.47±5.31 | 17/41 | "Chair rise test" |
Moller et al.29 | 11 | Multiple sclerosis | _____ | 7/4 | "5-repetition sit-to-stand test"* |
Poncumhak et al.25 | 66(V) and 16 (R) | Incomplete spinal Cord injury | (V): 50.9±13.4 and 50.2±9.5 (R): 50.8±10.3 | _____ | "Five times sit-to-stand test"* |
Wang et al.28 | 108(RIS) and 22(R T-RT) | Cerebral palsy | n=108: 8.1±1.8 | 65/43 | "Five times sit-to-stand test"* |
Suttanon et al.26 | 14 | Alzheimer disease | 79.57 ± 6.19 | 7/7 | "Five times sit-to-stand test"* |
Duncan et al.9 | 80(V) and 10 (R T-RT and R IE) | Parkinson disease | n=80: 67 ± 9.0 | 47/33 | "Five times sit-to-stand test"* |
Villamonte et al.8 | 21 | Down syndrome | Between 5 and 31 | 10/11 | "Sit-to-stand test" |
Mong et al.23 | 12 | Chronic stroke | 60 ± 4.8 | 6/6 | "5-repetition sit-to-stand test"* |
Beninato et al.21 | 27 | Chronic stroke | 57.2 ± 12.4 | 12/15 | "Five times sit-to-stand test"* |
Thomas et al.27 | 10 | Dementia | 80.5±6.2 | F | "Sit-to-stand"* |
n: number of subjects; M/F: male/female; V: validity; R: reliability; RIS: reliability intra-session; RT-RT: test-retest reliability; RIE: inter-rater reliability; _____: not described
related to the same test: "five-repetition sit-to-stand test"